Navigation Links
Atlanta’s NeuroTrials Research Studying Link Between Sleep and Parkinson’s Disease
Date:3/30/2017

Experts estimate 30 to 50% of people with Parkinson’s disease (PD) are excessively sleepy during the day, severely affecting their quality of life. What’s unclear is if their sleepiness is because of the disease or because of their medication. NeuroTrials Research, a clinical trials facility in Atlanta, is the only one in Georgia and only one of 15 locations nationwide charged with helping to find the answer to this “chicken and egg” question.

“This is the first study to focus on improving the quality of life for Parkinson’s patients by looking at the links between the disease and sleep,” said Dr. Russell Rosenberg, NeuroTrials Research founder and CEO. “Instead of focusing on the cure, in this unique proof of concept study, we’re trying to better patient’s lifestyle. They can stay on their current medication if they’re stable and that’s a very comforting situation for them.”

Doctors at NeuroTrials are accepting people to participate in the study who are 35-80 years old, are on stable treatment for their Parkinson’s yet experience excessive sleepiness. They must be otherwise healthy and may be compensated for time and travel.

Providing help in Atlanta … for the national good
Two gentlemen are participating in the study at NeuroTrials Research in hopes of finding relief from their own excessive sleepiness but also to help advance research into Parkinson’s.

“I was never a big nap person but since the diagnosis of Parkinson’s, if I sit down in a comfortable chair and the TV is on, I can be out like a light in a couple of minutes. It can be at noon, at 3 in the afternoon or 8 at night,” said Benton Ashby, 76, from Atlanta.

Ashby was diagnosed with PD in 2007 when his body became “like rubber” and he couldn’t get up, which was especially startling because it happened just three weeks after he ran a half marathon.

Gunther Eichler, 73, from Alpharetta, similarly experiences excessive sleepiness during the day. He’s been living with Parkinson’s since 2003 when shaking in his left hand was the first indication of the disease’s onset. In fact, before he was diagnosed with the disease, he once fell asleep at the wheel and “it almost killed me,” he said.

“I hit a road sign which made such a loud noise that it woke me up. I was headed straight for a bridge and I woke me up just in time,” Eichler, a veteran, said. He no longer drives.

Fatigue and Parkinson’s closely linked in online searches
In related news, a study was published in early February in the Journal of Parkinson’s Disease that analyzed top Parkinson’s disease literature and online search patterns. The study revealed that “fatigue” was one of the highest ranked search terms, suggesting a direct link to how a patient’s quality of life is impacted.

Parkinson’s disease affects up to one million people in the U.S. and doctors diagnose up to 60,000 new cases annually. Typically striking men 50 percent more than women, the average age of onset is 60, but early onset, beginning before age 50, accounts for five to 10 percent of cases.
Learn more at http://www.NeuroTrials.com or call 404-851-9934 for more information about the disease or the current study.

About NeuroTrials Research
Founded in 1997, NeuroTrials Research (NTR) is a nationally-recognized early- to late-phase inpatient and outpatient clinical research site located in the Atlanta suburb of Sandy Springs. Focused on neurological disorders including Alzheimer’s, migraine headaches, Parkinson’s and various sleep-related conditions, the research facility has a 12,000 square foot facility that includes a 15-bed, state-of-the-art sleep lab and inpatient clinical research unit designed specifically for the comfort and safety of clinical trial participants. Dr. Russell Rosenberg, PhD, D.ABSM, is NTR’s founder and CEO and a former chairman of the National Sleep Foundation. Learn more at http://www.NeuroTrials.com or call 404-851-9934 for more information.

About Clinical Trials
More than 2,500 volunteers have been study participants in 175+ clinical trials at NeuroTrials Research. Qualified study participants receive free medical evaluations, treatment and are compensated for their time and travel. Nationwide, 2.3 million people participate in 80,000 U.S. clinical trials annually; 70% of participants say they would volunteer again; approximately 178,000 studies enroll worldwide annually; more than 120 new drugs get FDA approval each year; and it takes 10 years of lab study before a treatment can be tested on humans.

# # #

Read the full story at http://www.prweb.com/releases/2017/04/prweb14200598.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related medicine news :

1. GPT Provides Mercy Care with Telemedicine Equipment to Support Atlanta’s Homeless Community
2. PT Solutions Opens New Location in Atlanta’s Morningside Neighborhood, Company’s First Inside I-285
3. Georgia State, Morehouse Partner To Tackle Diabetes, Heart Disease In Atlanta’s Minority Communities
4. Atlanta’s New Troubled Teen Helpline Is Making a Difference in the Community
5. Report Promotes Reforms to Teacher Education Programs but Ignores Past Research and Present Context
6. Renowned, Austin Facial Plastic Surgeon Contributes Ground-Breaking Research on Improving Hemostasis During Rhytidectomy Procedures
7. Advantexe Launches Strategy Execution Research Study
8. LEAD Coalition Urges Congress to Strengthen Alzheimer’s Research, Care and Support; Executive Director Warns President’s Budget Blueprint Would Reverse Progress
9. Author Richard Hostetter‘s Newly Released “A Respectful Response To Atheist Manifesto” is a Well-researched and Scripture-based Rebuttal to Claims that there is no God
10. The Rett Syndrome Research Trust Announces Roadmap to Cure Devastating Neurological Disorder that Afflicts 350,000 Girls and Women
11. Burke Medical Research Institute Partners with Blythedale Children’s Hospital
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/20/2017)... ... June 20, 2017 , ... In his newly appointed role ... May, Ph.D., recently accepted the distinguished Sun Corridor Export Award for his company’s ... (WNB), and 16 other businesses from Pima, Pinal, and Maricopa counties in Arizona, ...
(Date:6/20/2017)... West Hempstead, NY (PRWEB) , ... June 20, ... ... most experienced in the security systems industry has been selected as the partner ... , Amtrak is a passenger railroad service that provides medium- and long-distance intercity ...
(Date:6/20/2017)... ... 2017 , ... John D'Eri, CEO of Rising Tide Car Wash , ... during the Autism Society of America 's 49th annual conference to be ... Foundation (DJFF) was founded in 2002 as the nation's first autism organization focused ...
(Date:6/20/2017)... ... June 20, 2017 , ... MEDI+SIGN, ... like to officially welcome Anthony Stanowski, DHA, FACHE to the MEDI+SIGN Advisory Board. ... and expertise in healthcare will provide invaluable direction for the company,” says Andrew ...
(Date:6/20/2017)... ... , ... The law firm of Momkus McCluskey Roberts LLC congratulates ... DuPage County Bar Association’s Board of Directors. Cassioppi officially took on the leadership role ... Oak Brook. Momkus McCluskey Roberts LLC attorney Stacey A. McCullough was also installed as ...
Breaking Medicine News(10 mins):
(Date:6/1/2017)... , June 1, 2017 Nutriceutical Holdings (NH), ... Recommended Solutions (VRS), and KD Pharma Group have decided ... Holdings by KD Pharma Group. KD Pharma Group will ... option to acquire the entire company. "We ... They are committed to growing the NH companies by ...
(Date:5/26/2017)... -- Endo International plc (NASDAQ: ENDP ) announced today ... the Company in a fireside chat at Goldman Sachs, 38 ... 2017 at 10:40 a.m. PT / 1:40 p.m. ET. The ... Rancho Palos Verdes, CA. A live ... on the Company,s website at http://www.endo.com/investors/overview . Participants should ...
(Date:5/22/2017)... 22, 2017  As the specialty pharmacy industry ... to make the revolutionary shift from volume-based to ... ensuring positive patient outcomes and shaping the future ... focus away from clinical trials and toward data ... specialty drug therapy utilization in precise patient populations. ...
Breaking Medicine Technology: